CDK4 and neoplasm: A putative role of the CDK4/6 signaling and the cyclin inhibitor p21 in the immune status of colorectal cancer and the anti-tumor fitness of infiltrating CD4+ T cells was proposed in a study of colorectal cancer in mice [56].